About Zhejiang Hisoar Pharmaceutical
Zhejiang Hisoar Pharmaceutical is a publicly listed company based in Taizhou (China) founded in 1966. Speciality raw materials, fine chemicals, and dye intermediates are manufactured. The company has 2,610 employees. Its focus areas include Diversified Pharmaceuticals.
Company details
Founded in 1966, Zhejiang Hisoar Pharmaceutical is based in Taizhou, China. Operations focus on the production of speciality raw materials, fine chemicals, and dyes along with dye intermediates within the chemical and pharmaceutical sectors. Manufacturing activities are conducted to support industrial applications, with emphasis placed on quality standards and supply chain efficiency in the domestic market.
- Headquarters Taizhou, China
- Employees 2,610
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hisoar.com
- Social LinkedIn
- Legal Name Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A
- Annual Revenue$264.25 M (USD)-4.16as on Dec 31, 2025
- Net Profit-$13.01 M (USD)72.42as on Dec 31, 2025
- EBITDA$32.59 M (USD)12.8as on Dec 31, 2025
- Employee Count2,610
IPO & Listings of Zhejiang Hisoar Pharmaceutical
Zhejiang Hisoar Pharmaceutical is a publicly listed company on the SZSE with ticker symbol 002099 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Dec 2006
- Listed onSSE: 2099
- Listed entityZhejiang Hisoar Pharmaceutical Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE000001PY2
- Share price6.17 CNY (+0.98% on the day) · 2026-10-14
- Market capitalisation9,842,165,596.00 CNY
- EPS (diluted, trailing year)-0.11 CNY
- Volume (last session)18,871,258
Financials of Zhejiang Hisoar Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.85B CNY | -91.1M CNY | 228.1M CNY |
| 2024 | 1.93B CNY | -330.3M CNY | 202.2M CNY |
| 2023 | 2.14B CNY | -420.1M CNY | 88.9M CNY |
| 2022 | 2.70B CNY | 88.0M CNY | 424.7M CNY |
| 2021 | 2.47B CNY | 95.2M CNY | 410.5M CNY |
Detailed financial statements for Zhejiang Hisoar Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zhejiang Hisoar Pharmaceutical
Complete news archive for Zhejiang Hisoar Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zhejiang Hisoar Pharmaceutical
Zhejiang Hisoar Pharmaceutical was founded in 1966.
Zhejiang Hisoar Pharmaceutical is headquartered in Taizhou, China. It is registered at Taizhou, Jiangsu, China.
Zhejiang Hisoar Pharmaceutical has 2,610 employees.
Annual revenue of Zhejiang Hisoar Pharmaceutical is $264.25M as on Dec 31, 2025.
Founded in 1966, Zhejiang Hisoar Pharmaceutical is based in Taizhou, China. Operations focus on the production of speciality raw materials, fine chemicals, and dyes along with dye intermediates within the chemical and pharmaceutical sectors. Manufacturing activities are conducted to support industrial applications, with emphasis placed on quality standards and supply chain efficiency in the domestic market.
Yes, Zhejiang Hisoar Pharmaceutical is publicly traded on SZSE under the ticker symbol 002099.